AMANDA GODDARD: Open Payments
NPI 1356570576 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,519 in 101 payments from 17 companies in 2025. Trend: 2023 $2,345 · 2024 $1,635 · 2025 $1,519
Food & beverage: $1,519
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 15 | $293 |
| MAYNE PHARMA COMMERCIAL LLC | 31 | $220 |
| ABBVIE INC. | 9 | $200 |
| UCB, Inc. | 7 | $141 |
| E.R. Squibb & Sons, L.L.C. | 9 | $140 |
| Novartis Pharmaceuticals Corporation | 5 | $101 |
| Arcutis Biotherapeutics, Inc. | 5 | $87 |
| Amgen Inc. | 4 | $72 |
| Lilly USA, LLC | 3 | $51 |
| GENZYME CORPORATION | 2 | $48 |
Products named: NEMLUVIO, SKYRIZI, Bimzelx, Sotyktu, Zoryve, COSENTYX, OTEZLA, DUPIXENT.
Industry payments across MO — which companies pay providers there.
